---
title: "Diagnostic studies of pheochromocytoma"
slug: "diagnostic-studies-of-pheochromocytoma"
date: "2023-08-03"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[pheochromocytoma]]

# Diagnostic studies of pheochromocytoma

(JCEM 2014;99:1915)

- 24Â° urinary fractionated metanephrines:
  - 98% Se,
  - 98% Sp.
  - Screening test of choice if low-risk (b/c false âŠ• with:
    - severe illness,
    - renal failure,
    - OSA,
    - labetalol due to assay interference
    - acetaminophen,
    - TCAs,
    - medications containing sympathomimetics
- Plasma fractionated metanephrines:
  - 97% Se, 91% Sp.
  - Screening test of choice if high risk, but â†‘ rate of false âŠ• in low-prevalence population.
  - False âŠ• rate lower if patient supine for 30 min (estimated 2.8Ã— â†‘ false âŠ• if seated
- Adrenal CT or T2-weighted MRI;
  - PET for known metastatic disease or to localize nonadrenal mass but usually easy to find;
  - consider MIBG scintigraphy if CT/MRI âŠ–
- Consider genetic testing in all Pts (J Intern Med 2019;285:187)
